|

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

RECRUITINGN/ASponsored by University of Texas Southwestern Medical Center
Actively Recruiting
PhaseN/A
SponsorUniversity of Texas Southwestern Medical Center
Started2025-02-10
Est. completion2027-12-10
Eligibility
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06593327

Summary

A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive prevention strategy among patients with high risk focused on implementation of evidence-based HF preventive therapies.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Primary Care Provider that sees diabetes patients in clinic

Exclusion Criteria:

* Provider does not see patients with Diabetes

Conditions6

Cardiometabolic DiseasesDiabetesDiabetic CardiomyopathyHeart DiseaseHeart FailureType 2 Diabetes

Locations1 site

University of Texas Southwestern Medical Center
Dallas, Texas, 75209
Ambarish Pandey, MD214-645-9868ambarish.pandey@utsouthwestern.edu

Browse More Trials

Heart Disease trialsDiabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.